Wuhan General Gr Chn
Wuhan General Group (China), Inc., a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Reno, Nevada.
Wuhan General Gr Chn (WUHN) - Total Assets
Latest total assets as of September 2022: $191.36K USD
Based on the latest financial reports, Wuhan General Gr Chn (WUHN) holds total assets worth $191.36K USD as of September 2022.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Wuhan General Gr Chn - Total Assets Trend (2006–2021)
This chart illustrates how Wuhan General Gr Chn’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Wuhan General Gr Chn - Asset Composition Analysis
Current Asset Composition (December 2021)
Wuhan General Gr Chn's total assets of $191.36K consist of 77.7% current assets and 22.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 14.1% |
| Accounts Receivable | $116.61K | 15.3% |
| Inventory | $67.95K | 8.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2006–2021)
This chart illustrates how Wuhan General Gr Chn's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Wuhan General Gr Chn's current assets represent 77.7% of total assets in 2021, an increase from 0.0% in 2006.
- Cash Position: Cash and equivalents constituted 14.1% of total assets in 2021, up from 0.5% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 4.0% in 2006.
- Asset Diversification: The largest asset category is accounts receivable at 15.3% of total assets.
Wuhan General Gr Chn Competitors by Total Assets
Key competitors of Wuhan General Gr Chn based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Wuhan General Gr Chn - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Wuhan General Gr Chn generates 0.02x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Wuhan General Gr Chn is currently not profitable relative to its asset base.
Wuhan General Gr Chn - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.03 | 1.22 | 1.30 |
| Quick Ratio | 0.02 | 1.10 | 1.20 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-6.97 Million | $ 42.48 Million | $ 48.88 Million |
Wuhan General Gr Chn - Advanced Valuation Insights
This section examines the relationship between Wuhan General Gr Chn's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.04 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 28.0% |
| Total Assets | $763.74K |
| Market Capitalization | $2.36K USD |
Valuation Analysis
Below Book Valuation: The market values Wuhan General Gr Chn's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Wuhan General Gr Chn's assets grew by 28.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Wuhan General Gr Chn (2006–2021)
The table below shows the annual total assets of Wuhan General Gr Chn from 2006 to 2021.
| Year | Total Assets | Change |
|---|---|---|
| 2021-12-31 | $763.74K | +28.03% |
| 2020-12-31 | $596.55K | +611.73% |
| 2019-12-31 | $83.82K | -99.97% |
| 2012-12-31 | $286.58 Million | +5.14% |
| 2011-12-31 | $272.57 Million | +12.40% |
| 2010-12-31 | $242.51 Million | +39.52% |
| 2009-12-31 | $173.82 Million | +12.09% |
| 2008-12-31 | $155.07 Million | +54.52% |
| 2007-12-31 | $100.36 Million | +99.06% |
| 2006-12-31 | $50.42 Million | -- |